Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Goiter 1Cystitis, Interstitial 1

Interventions

pembrolizumab 1251Specimen Handling 867Carboplatin 816Magnetic Resonance Spectroscopy 803Cyclophosphamide 794Cisplatin 715Nivolumab 646Paclitaxel 623Radiotherapy 564Gemcitabine 562Biopsy 529Bevacizumab 468Dexamethasone 433fludarabine 404Docetaxel 370venetoclax 365Oxaliplatin 362Fluorouracil 352Capecitabine 350atezolizumab 341Rituximab 326durvalumab 326Doxorubicin 313Radiosurgery 305Pemetrexed 302Drug Therapy 294Standard of Care 292Ipilimumab 289Etoposide 279Radiation 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hyaluronic Acid × 1 year × Clear all
NCT07495072 2026-03-27

PRO-GAG

BLAD-HYA Group

Phase NA Recruiting
56 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Cystitis, Interstitial

NCT05851560 2025-09-19

Prospective Comparison of the Effect on Antiadhesive Barriers During Thyroid Surgery

National Taiwan University Hospital

Phase 1 Completed
45 enrolled
Head & Neck

Goiter, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡